PRTN3 and rheumatoid arthritis: In this inception cohort of RA patients classified according to the ACR/EULAR 2010 criteria, the prevalence of ACPA reactivities differed in subgroups according to anti-CCP and RF status, and ACPA reactivity levels decreased after initiation of DMARD treatment.